The First Human Trial to Reverse Aging Just Got FDA Clearance: What Epigenetic Reprogramming Actually Is

Harvard geneticist David Sinclair’s Life Biosciences received FDA approval in January 2026 to begin the world’s first human trial of partial epigenetic reprogramming — a technology that has already reversed aging in mouse and primate eyes. Here is what the science actually shows, and what it does not yet prove.